Paul Gerskowitch

Strategic Transaction Advisor, Life Sciences & Healthcare

Dr V Paul Gerskowitch was appointed to SBC’s Expert Panel at its inception. In this role he participated in various seminars and advised on funding strategies.  He supports early stage companies under the SBC/BIS mentoring challenge fund, eg, Cambridge Allergy Therapy Ltd.

Paul is happy to assist SBC companies with:

  • Analysis and validation of company technologies
  • Analysis and validation of clinical development programmes
  • Preparation of business plans and informational memoranda to support a range of value-added transactions in the biotechnology, diagnostics, medical device, regenerative medicine and pharmaceutical sectors
  • Company mentoring

Paul is a highly experienced pharmaceutical and life sciences industry executive.  He directed R&D programmes in gastrointestinal, cardiovascular, CNS and oncology at several major pharmaceutical and biotechnology companies where he held appointments at either Chairman, CEO, or Director level.  Later he focused on advising strategic transactions, eg, licensing, corporate venturing, M&A, divestment, and trade sales across a diverse range o fbiotechnology and biopharmaceutical businesses located in Europe and the USA. Paul was a member of the University of Strathclyde’s International Healthcare Technologies Advisory Panel, is a member of the British Heart Foundation’s Translational Awards Group and retained by several corporate clients.


Funding Partners: